SK285683B6 - Polosyntetické taxány, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Polosyntetické taxány, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK285683B6
SK285683B6 SK1056-2002A SK10562002A SK285683B6 SK 285683 B6 SK285683 B6 SK 285683B6 SK 10562002 A SK10562002 A SK 10562002A SK 285683 B6 SK285683 B6 SK 285683B6
Authority
SK
Slovakia
Prior art keywords
hydrogen
group
alkyl
tert
dehydro
Prior art date
Application number
SK1056-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK10562002A3 (sk
Inventor
Ezio Bombardelli
Alessandro Pontiroli
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of SK10562002A3 publication Critical patent/SK10562002A3/sk
Publication of SK285683B6 publication Critical patent/SK285683B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1056-2002A 2000-01-18 2001-01-15 Polosyntetické taxány, farmaceutický prostriedok s ich obsahom a ich použitie SK285683B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI000056A IT1317731B1 (it) 2000-01-18 2000-01-18 Tassani semisintetici con attivita' antitumorale ed antiangiogenetica.
PCT/EP2001/000386 WO2001053282A1 (en) 2000-01-18 2001-01-15 Semi-synthetic taxanes with antitumor and antiangiogenetic activities

Publications (2)

Publication Number Publication Date
SK10562002A3 SK10562002A3 (sk) 2002-11-06
SK285683B6 true SK285683B6 (sk) 2007-06-07

Family

ID=11443708

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1056-2002A SK285683B6 (sk) 2000-01-18 2001-01-15 Polosyntetické taxány, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (24)

Country Link
US (2) US6589979B2 (cs)
EP (1) EP1248776B1 (cs)
JP (1) JP4986354B2 (cs)
KR (1) KR100813704B1 (cs)
CN (1) CN1176916C (cs)
AT (1) ATE271044T1 (cs)
AU (1) AU781650B2 (cs)
CA (1) CA2397591C (cs)
CZ (1) CZ301251B6 (cs)
DE (1) DE60104281T2 (cs)
DK (1) DK1248776T3 (cs)
ES (1) ES2223778T3 (cs)
HK (1) HK1049998B (cs)
HU (1) HU229347B1 (cs)
IL (1) IL150787A0 (cs)
IT (1) IT1317731B1 (cs)
NO (1) NO329403B1 (cs)
PL (1) PL202591B1 (cs)
PT (1) PT1248776E (cs)
RU (1) RU2259363C2 (cs)
SI (1) SI1248776T1 (cs)
SK (1) SK285683B6 (cs)
TR (1) TR200401811T4 (cs)
WO (1) WO2001053282A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1688415A1 (en) * 2004-12-07 2006-08-09 Aventis Pharma S.A. Cytotoxic agents comprising new C-2 modified taxanes
ITMI20050415A1 (it) * 2005-03-15 2006-09-16 Indena Spa Derivati tassanici semi-sintetici ad attivita' antitumorale
ES2701076T3 (es) 2012-11-24 2019-02-20 Hangzhou Dac Biotech Co Ltd Enlazadores hidrofílicos y sus usos para la conjugación de fármacos a las moléculas que se unen a las células
CA2938919C (en) 2014-02-28 2020-12-29 Hangzhou Dac Biotech Co., Ltd Charged linkers and their uses for conjugation
CN108449940B (zh) 2015-07-12 2021-06-08 杭州多禧生物科技有限公司 与细胞结合分子的共轭偶联的桥连接体
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CA3042442C (en) 2016-11-14 2024-01-02 Hangzhou Dac Biotech Co., Ltd Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses of such conjugates with the linkers
EP4426727A2 (en) 2021-11-03 2024-09-11 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
CA2109861C (en) * 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
RU2134688C1 (ru) * 1994-07-26 1999-08-20 Индена С.П.А. Полусинтетический таксан, промежуточные соединения, способы получения и фармацевтическая композиция

Also Published As

Publication number Publication date
HK1049998B (zh) 2005-04-01
HU229347B1 (hu) 2013-11-28
KR100813704B1 (ko) 2008-03-13
NO329403B1 (no) 2010-10-11
RU2002119060A (ru) 2004-01-10
CA2397591C (en) 2009-10-20
CZ301251B6 (cs) 2009-12-23
CA2397591A1 (en) 2001-07-26
KR20020068082A (ko) 2002-08-24
SK10562002A3 (sk) 2002-11-06
HUP0204344A2 (en) 2003-05-28
AU781650B2 (en) 2005-06-02
CN1176916C (zh) 2004-11-24
TR200401811T4 (tr) 2004-09-21
ES2223778T3 (es) 2005-03-01
PT1248776E (pt) 2004-10-29
JP4986354B2 (ja) 2012-07-25
HK1049998A1 (en) 2003-06-06
US20030028038A1 (en) 2003-02-06
NO20023428D0 (no) 2002-07-17
CZ20022478A3 (cs) 2002-10-16
SI1248776T1 (en) 2004-10-31
PL356272A1 (en) 2004-06-28
RU2259363C2 (ru) 2005-08-27
ITMI20000056A1 (it) 2001-07-18
IL150787A0 (en) 2003-02-12
ITMI20000056A0 (it) 2000-01-18
PL202591B1 (pl) 2009-07-31
DE60104281T2 (de) 2005-08-18
US6589979B2 (en) 2003-07-08
JP2003520792A (ja) 2003-07-08
DE60104281D1 (de) 2004-08-19
DK1248776T3 (da) 2004-11-22
IT1317731B1 (it) 2003-07-15
CN1395571A (zh) 2003-02-05
WO2001053282A1 (en) 2001-07-26
USRE39723E1 (en) 2007-07-10
AU3369401A (en) 2001-07-31
HUP0204344A3 (en) 2004-01-28
ATE271044T1 (de) 2004-07-15
EP1248776A1 (en) 2002-10-16
NO20023428L (no) 2002-09-16
EP1248776B1 (en) 2004-07-14

Similar Documents

Publication Publication Date Title
AU730174B2 (en) Novel taxane derivatives
US5157049A (en) Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
US4942184A (en) Water soluble, antineoplastic derivatives of taxol
US5750562A (en) 10-deacetylbaccatine III and 10-deacetyl 14β-hydroxybaccatine III derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
US5547981A (en) Taxol-7-carbazates
SK285683B6 (sk) Polosyntetické taxány, farmaceutický prostriedok s ich obsahom a ich použitie
WO2000010988A1 (en) Water soluble analogs and prodrugs of paclitaxel
SK139994A3 (en) Taxane derivatives, their preparation and compositions containing same
BG64889B1 (bg) Таксани с естерен заместител на с10 и приложението им като антитуморни агенти
EP2213667A1 (en) Cephalomannine derivatives and their preparation, medicinal composition and use

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20200115